Haleon PLC Sponsored ADR (HLN) vs Dr. Reddy's Laboratories Ltd (RDY)

Haleon PLC Sponsored ADR and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Haleon PLC Sponsored ADR is the larger, with a market value of $40.2B against $12.1B — 3.3× the size. Haleon PLC Sponsored ADR trades at the lower P/E: 20.5× against 44.4×. Haleon PLC Sponsored ADR has the higher net margin (11.2% vs 8.06%) and the lower return on invested capital (0.00% vs 4.77%). Only Haleon PLC Sponsored ADR pays a dividend (2.16%). Across the 22 metrics below, Haleon PLC Sponsored ADR leads on 13 and Dr. Reddy's Laboratories Ltd on 9.

Valuation

Metric HLN RDY Drug Manufacturers Specialty & Generic median
P/E 20.48 44.42 20.55
P/S 2.32 3.63 2.08
P/B 1.90 2.98 1.79
Price to free cash flow 9.23 126.01 16.29
EV/EBITDA 12.22 22.88 12.22
EV/Sales 2.87 3.61 2.87
Earnings yield 4.88% 2.25% (15.94%)
Free cash flow yield 10.84% 0.79% 0.00%

Profitability

Metric HLN RDY Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 49.16% 53.51%
Operating margin 17.93% 9.20% 0.00%
Net margin 11.18% 8.06% (2.45%)
Free cash flow margin 0.00% 2.88% 0.00%
Return on equity 0.00% 6.60% (0.80%)
Return on assets 0.00% 4.44% (1.67%)
Return on invested capital 0.00% 4.77% 0.00%

Growth

Metric HLN RDY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (15.51%) 5.22%
EPS growth (last fiscal year) 22.50% (30.38%) 42.91%
Revenue growth, 5-year CAGR 1.43% 6.66% 7.24%
Net income growth, 5-year CAGR 6.98% 14.08% 0.00%

Health

Metric HLN RDY Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.19 0.04
Current ratio 0.69 1.93 2.41
Net debt to EBITDA 2.63 (0.15) 1.01

Dividend

Metric HLN RDY Drug Manufacturers Specialty & Generic median
Dividend yield 2.16% 0.00% 1.45%
Payout ratio — 0.00 0.27

Size

Metric HLN RDY Drug Manufacturers Specialty & Generic median
Market cap 40.24b 12.10b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack